The name may be Radiological Society of North America, but the society has seen major growth from outside North America during the last 10 years in both membership and attendance at its annual meeting, according to RSNA president Dr. Brian C. Lentle.
The name may be Radiological Society of North America, but the society has seen major growth from outside North America during the last 10 years in both membership and attendance at its annual meeting, according to RSNA president Dr. Brian C. Lentle.
"When one examines the absolute numbers, to steal a concept from cell biology, the doubling times in North American and international attendance are about 36 and 13 years, respectively, based on marginal trends observed in the most recent decade," Lentle said in Sunday's opening address.
This year is no exception. The number of preregistered North American professionals as of mid-November was up 7%, while non-North American professionals had increased by 11%.
Abstract submissions to the annual meeting reflect the same trend, with a steady increase in international contributions. In 2002 and 2003, submissions topped the 5000 mark, while dipping just below that number this year. Overall, non-North American submissions have increased 30% in since 1997, Lentle said.
In contrast, totals of accepted papers from North America from 1993 to 2003 have remained largely unchanged.
Most papers accepted from outside the continent come from Western Europe, followed by the Far East. But the number of countries submitting papers has also increased, from 32 in 1993 to 48 in 2003.
The RSNA journal Radiology has seen an upswing in the amount of international manuscripts submitted as well, from less than 50% in 1998 to more than 60% last year.
"These trends have all occurred without an aggressive plan by RSNA to promote itself beyond the boundaries of this continent," Lentle said.
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
New Interventional Radiology Research Shows Merits of Genicular Artery Embolization for Knee OA
December 3rd 2024In a cohort of over 160 patients with knee osteoarthritis (OA), including grade 4 in nearly half of the cases, genicular artery embolization led to an 87 percent improvement in the quality of life index, according to research presented at the recent RSNA conference.
Siemens Healthineers Debuts New Photon-Counting CT Systems at RSNA
December 2nd 2024Debuting at the Radiological Society of North American (RSNA) conference, the new photon-counting computed tomography (PPCT) scanners Naeotom Alpha.Pro and Naeotom Alpha.Prime reportedly combine rapid scan times with high-resolution precision.